10 costliest medical conditions

Sun Life Financial, based in Wellesley, Mass., compiled the costliest medical conditions covered by Sun Life stop-loss insurance from 2012 to 2015 in its fourth annual Top Ten Catastrophic Claims Conditions report.

Advertisement

The report showed the amount of million-dollar-plus claims increased by 25 percent since last year.

Here are the top 10 costliest medical conditions for 2016 ranked by value of stop-loss claims reimbursements:

  • Malignant neoplasm (cancer) $429.5 million

  • Leukemia/lymphoma/multiple myeloma $188.6 million

  • Chronic/end-stage renal disease $156.6 million

  • Congenital Anomalies $96.3 million

  • Disorders relating to short gestation and low birth weight — $75.2 million

  • Transplant — $62.2 million

  • Congestive heart failure — $57.8 million

  • Cerebrovascular disease (brain blood vessels) — $57.4 million

  • Pulmonary collapse/respiratory failure — $55.0 million

  • Septicemia (infection) — $54.7 million

More articles on healthcare finance:

GOP backs new emergency fund for public health crises
Medicare doubled spending on hepatitis C drugs in 5 months
Oregon price report explains payer exodus from some counties

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Financial Management

  • Baylor College of Medicine and Texas Children’s Hospital established an affiliation more than 70 years ago in the Texas Medical…

  • Fitch revised Ontario, Calif.-based Prime Healthcare Services’ outlook to positive and affirms its “B” rating.  The revised outlook reflects Fitch’s…

  • Brentwood, Tenn.-based Lifepoint Health, a health system owned by private equity firm Apollo Global Management, has largely grown over the…

Advertisement

Comments are closed.